The stock of CymaBay Therapeutics Inc (NASDAQ:CBAY) is a huge mover today! About 135,788 shares traded. CymaBay Therapeutics Inc (NASDAQ:CBAY) has risen 73.03% since August 31, 2016 and is uptrending. It has outperformed by 64.44% the S&P500.The move comes after 9 months negative chart setup for the $115.32M company. It was reported on Apr, 7 by Barchart.com. We have $3.69 PT which if reached, will make NASDAQ:CBAY worth $8.07 million less.
Raging Capital Management Llc increased Builders Firstsource Inc (BLDR) stake by 153.14% reported in 2016Q4 SEC filing. Raging Capital Management Llc acquired 3.53 million shares as Builders Firstsource Inc (BLDR)’s stock declined 3.77%. The Raging Capital Management Llc holds 5.84M shares with $64.05M value, up from 2.31 million last quarter. Builders Firstsource Inc now has $1.72 billion valuation. The stock rose 0.17% or $0.02 reaching $15.1 per share. About 633,134 shares traded. Builders FirstSource, Inc. (NASDAQ:BLDR) has risen 9.75% since August 31, 2016 and is uptrending. It has outperformed by 1.16% the S&P500.
Among 3 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 7 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by H.C. Wainwright on Monday, January 30. The firm earned “Neutral” rating on Wednesday, June 1 by H.C. Wainwright. The firm has “Buy” rating by Roth Capital given on Friday, July 1. H.C. Wainwright maintained the shares of CBAY in report on Wednesday, January 4 with “Neutral” rating. As per Wednesday, March 30, the company rating was maintained by H.C. Wainwright. The stock of CymaBay Therapeutics Inc (NASDAQ:CBAY) earned “Buy” rating by H.C. Wainwright on Tuesday, September 8. As per Tuesday, July 21, the company rating was initiated by Piper Jaffray.
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $115.32 million. The Firm is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. It currently has negative earnings. The Company’s product candidates include Arhalofenate, MBX-8025 and MBX-2982.
Investors sentiment increased to 1.33 in 2016 Q4. Its up 0.36, from 0.97 in 2016Q3. It increased, as 28 investors sold BLDR shares while 44 reduced holdings. 39 funds opened positions while 57 raised stakes. 85.21 million shares or 6.07% less from 90.71 million shares in 2016Q3 were reported. Essex Inv Ltd Liability Corporation stated it has 0.21% of its portfolio in Builders FirstSource, Inc. (NASDAQ:BLDR). Lorber David A accumulated 1.73% or 9,291 shares. Blackrock Group Inc Limited has 0% invested in Builders FirstSource, Inc. (NASDAQ:BLDR) for 44,828 shares. Frontfour Cap Limited Liability Corporation has invested 1.68% in Builders FirstSource, Inc. (NASDAQ:BLDR). Citadel Ltd Llc accumulated 276,369 shares. Tower Research Ltd Liability Corporation (Trc) holds 0% or 3,950 shares. Raymond James And reported 0% in Builders FirstSource, Inc. (NASDAQ:BLDR). New Generation Advisors Limited Liability Co reported 688,519 shares. Clearbridge Ltd Liability Corporation holds 0% or 171,053 shares in its portfolio. Balyasny Asset Mngmt Ltd Liability holds 0% or 50,000 shares. Benjamin F Edwards & Inc has invested 0.01% in Builders FirstSource, Inc. (NASDAQ:BLDR). 113,382 were accumulated by Cipher L P. Emerald Advisers Pa owns 15,019 shares. Redwood Cap Ltd Limited Liability Company accumulated 550,000 shares or 0.82% of the stock. Us Fincl Bank De reported 48,420 shares or 0% of all its holdings.
Among 7 analysts covering Builders Firstsource (NASDAQ:BLDR), 5 have Buy rating, 0 Sell and 2 Hold. Therefore 71% are positive. Builders Firstsource had 12 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, March 7 by Deutsche Bank. Credit Suisse initiated Builders FirstSource, Inc. (NASDAQ:BLDR) rating on Thursday, October 8. Credit Suisse has “Neutral” rating and $14 target. The stock has “Buy” rating by Deutsche Bank on Tuesday, September 8. On Friday, January 6 the stock rating was initiated by Barclays Capital with “Equal Weight”. The stock of Builders FirstSource, Inc. (NASDAQ:BLDR) has “Outperform” rating given on Wednesday, June 1 by FBR Capital. As per Tuesday, November 22, the company rating was initiated by Seaport Global Securities. The stock of Builders FirstSource, Inc. (NASDAQ:BLDR) has “Outperform” rating given on Wednesday, September 7 by Wedbush. The firm earned “Neutral” rating on Thursday, September 10 by Citigroup. Zacks downgraded the stock to “Buy” rating in Monday, August 10 report.
Since November 17, 2016, it had 0 insider purchases, and 7 selling transactions for $294.00 million activity. JLL Building Holdings – LLC sold 10.00 million shares worth $145.10 million. $742,000 worth of Builders FirstSource, Inc. (NASDAQ:BLDR) was sold by Tolly Morris E on Tuesday, March 7. SHERMAN FLOYD F sold 15,000 shares worth $229,800. 71,937 shares were sold by MCALEENAN DONALD F, worth $1.08 million. CROW M CHAD sold $1.61M worth of stock. LEVY PAUL S sold $145.10M worth of Builders FirstSource, Inc. (NASDAQ:BLDR) on Wednesday, March 8.
